Imaging Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Enzalutamide
Related studies linked through entity extraction aliases.
PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance
- Status
- COMPLETED
- Phase
- PHASE2
Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases
- Status
- TERMINATED
- Phase
- PHASE2
Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Management of Castration-Resistant Prostate Cancer with Oligometastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
- Status
- COMPLETED
- Phase
- PHASE3
Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Long-Term Specified Drug Use-Results Survey for Xtandi Capsule
- Status
- COMPLETED
- Phase
- N/A
Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone
- Status
- TERMINATED
- Phase
- PHASE2
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Enzalutamide for Bladder Cancer Chemoprevention
- Status
- TERMINATED
- Phase
- PHASE2
Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7
- Status
- COMPLETED
- Phase
- PHASE2